{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:22:16Z","timestamp":1776424936810,"version":"3.51.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In critically ill sepsis patients the use of certain antibiotics can be associated with adverse effects. This study investigates the relationship between the use of different classes of antibiotic during the intensive care unit stay and the 30-day mortality risk in patients with sepsis-associated encephalopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective observational study collected data from the Medical Information Mart for Intensive Care IV database between 2008 and 2019. The antibiotic classes assessed included cephalosporins, penicillins, carbapenems, quinolones, macrolides, and metronidazole. The Cox proportional hazards model was employed to assess the association between the use of different classes of antibiotic and mortality risk in patients with sepsis-associated encephalopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The 30-day mortality was 16.19% (643 out of 3974 patients). The use of penicillins (hazard ratio: 1.32, 95% confidence interval: 1.11\u20131.58, <jats:italic>P<\/jats:italic>\u2009=\u20090.002), macrolides (hazard ratio: 1.50, 95% confidence interval: 1.13\u20132.00, <jats:italic>P<\/jats:italic>\u2009=\u20090.005), and metronidazole (hazard ratio: 1.32, 95% confidence interval: 1.11\u20131.57, <jats:italic>P<\/jats:italic>\u2009=\u20090.002) were associated with a higher risk of 30-day mortality. The use of one, two, or more than three antibiotic classes were associated with an increased risk of 30-day mortality (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). In sepsis-associated encephalopathy patients aged\u2009\u2265\u200965\u00a0years, with Sequential Organ Failure Assessment scores\u2009\u2265\u20096, Charlson comorbidity index scores\u2009\u2265\u20092, Glasgow Coma Scale\u2009\u2265\u20098, experiencing acute kidney injury, and receiving opiates or propofol, the number of administered antibiotic classes was significantly associated with increased 30-day mortality risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We found an association between penicillins, macrolides, and metronidazole usage and 30-day mortality in sepsis-associated encephalopathy patients that needs future prospective randomized control trials to establish causal relationship.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-11139-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:23:36Z","timestamp":1751372616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relationship between antibiotic use and short-term risk of mortality in patients with sepsis-associated encephalopathy: a study based on the medical information mart for intensive care database"],"prefix":"10.1186","volume":"25","author":[{"given":"Shuwen","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanming","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"6","key":"11139_CR1","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s10753-021-01501-3","volume":"44","author":"Q Gao","year":"2021","unstructured":"Gao Q, Hernandes MS. Sepsis-associated encephalopathy and blood-brain barrier dysfunction. Inflammation. 2021;44(6):2143\u201350.","journal-title":"Inflammation"},{"issue":"Pt A","key":"11139_CR2","doi-asserted-by":"publisher","first-page":"110800","DOI":"10.1016\/j.intimp.2023.110800","volume":"124","author":"Y Hong","year":"2023","unstructured":"Hong Y, Chen P, Gao J, Lin Y, Chen L, Shang X. Sepsis-associated encephalopathy: from pathophysiology to clinical management. Int Immunopharmacol. 2023;124(Pt A):110800.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"11139_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s13054-023-04655-8","volume":"27","author":"R Sonneville","year":"2023","unstructured":"Sonneville R, Benghanem S, Jeantin L, de Montmollin E, Doman M, Gaudemer A, Thy M, Timsit JF. The spectrum of sepsis-associated encephalopathy: a clinical perspective. Crit Care. 2023;27(1):386.","journal-title":"Crit Care"},{"issue":"2","key":"11139_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s13311-020-00862-1","volume":"17","author":"A Mazeraud","year":"2020","unstructured":"Mazeraud A, Righy C, Bouchereau E, Benghanem S, Bozza FA, Sharshar T. Septic-associated encephalopathy: a comprehensive review. Neurotherapeutics. 2020;17(2):392\u2013403.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"11139_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/14787210.2020.1812384","volume":"19","author":"SC Tauber","year":"2021","unstructured":"Tauber SC, Djukic M, Gossner J, Eiffert H, Br\u00fcck W, Nau R. Sepsis-associated encephalopathy and septic encephalitis: an update. Expert Rev Anti Infect Ther. 2021;19(2):215\u201331.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"10","key":"11139_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrneurol.2012.183","volume":"8","author":"TE Gofton","year":"2012","unstructured":"Gofton TE, Young GB. Sepsis-associated encephalopathy. Nat Rev Neurol. 2012;8(10):557\u201366.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"11139_CR7","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00134-017-4807-z","volume":"43","author":"R Sonneville","year":"2017","unstructured":"Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, Mariotte E, Argaud L, Barbier F, Goldgran-Toledano D, et al. Potentially modifiable factors contributing to sepsis-associated encephalopathy. Intensive Care Med. 2017;43(8):1075\u201384.","journal-title":"Intensive Care Med"},{"issue":"4","key":"11139_CR8","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/cpt.2203","volume":"109","author":"CB Landersdorfer","year":"2021","unstructured":"Landersdorfer CB, Nation RL. Key challenges in providing effective antibiotic therapy for critically ill patients with bacterial sepsis and septic shock. Clin Pharmacol Ther. 2021;109(4):892\u2013904.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"11139_CR9","doi-asserted-by":"publisher","first-page":"106732","DOI":"10.1016\/j.ijantimicag.2023.106732","volume":"61","author":"S Einav","year":"2023","unstructured":"Einav S, Leone M, Martin-Loeches I. Sepsis and antibiotics: when should we deploy a parachute? Int J Antimicrob Agents. 2023;61(4):106732.","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"11139_CR10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/aas.13831","volume":"65","author":"SK Korang","year":"2021","unstructured":"Korang SK, Maagaard M, Feinberg JB, Perner A, Gluud C, Jakobsen JC. The effects of adding quinolones to beta-lactam antibiotics for sepsis. Acta Anaesthesiol Scand. 2021;65(8):1023\u201332.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"11139_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/antibiotics12010069","volume":"12","author":"V Jean-Michel","year":"2022","unstructured":"Jean-Michel V, Homey C, Devos P, Delannoy PY, Boussekey N, Caulier T, Leroy O, Georges H. Continuous infusion of high doses of cefepime in intensive care unit: assessment of steady-state plasma level and incidence on neurotoxicity. Antibiotics (Basel). 2022;12(1):69.","journal-title":"Antibiotics (Basel)"},{"issue":"10","key":"11139_CR12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","volume":"86","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S, Darby RR, Raibagkar P, Gonzalez Castro LN, Berkowitz AL. Antibiotic-associated encephalopathy. Neurology. 2016;86(10):963\u201371.","journal-title":"Neurology"},{"issue":"1","key":"11139_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/13651501.2020.1828933","volume":"26","author":"AV Pej\u010di\u0107","year":"2022","unstructured":"Pej\u010di\u0107 AV. Delirium associated with the use of macrolide antibiotics: a review. Int J Psychiatry Clin Pract. 2022;26(1):29\u201342.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"1","key":"11139_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-018-9147-6","volume":"267","author":"CG S\u00f8rensen","year":"2020","unstructured":"S\u00f8rensen CG, Karlsson WK, Amin FM, Lindelof M. Metronidazole-induced encephalopathy: a systematic review. J Neurol. 2020;267(1):1\u201313.","journal-title":"J Neurol"},{"issue":"1","key":"11139_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13054-018-2262-z","volume":"22","author":"JJ Grahl","year":"2018","unstructured":"Grahl JJ, Stollings JL, Rakhit S, Person AK, Wang L, Thompson JL, Pandharipande PP, Ely EW, Patel MB. Antimicrobial exposure and the risk of delirium in critically ill patients. Crit Care. 2018;22(1):337.","journal-title":"Crit Care"},{"key":"11139_CR16","doi-asserted-by":"publisher","first-page":"739265","DOI":"10.3389\/fncom.2021.739265","volume":"15","author":"L Zhao","year":"2021","unstructured":"Zhao L, Wang Y, Ge Z, Zhu H, Li Y. Mechanical learning for prediction of sepsis-associated encephalopathy. Front Comput Neurosci. 2021;15:739265.","journal-title":"Front Comput Neurosci"},{"issue":"11","key":"11139_CR17","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143.","journal-title":"Crit Care Med"},{"issue":"1","key":"11139_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-021-03736-w","volume":"25","author":"MS Niederman","year":"2021","unstructured":"Niederman MS, Baron RM, Bouadma L, Calandra T, Daneman N, DeWaele J, Kollef MH, Lipman J, Nair GB. Initial antimicrobial management of sepsis. Crit Care. 2021;25(1):307.","journal-title":"Crit Care"},{"key":"11139_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40560-020-00459-y","volume":"8","author":"Y Yang","year":"2020","unstructured":"Yang Y, Liang S, Geng J, Wang Q, Wang P, Cao Y, Li R, Gao G, Li L. Development of a nomogram to predict 30-day mortality of patients with sepsis-associated encephalopathy: a retrospective cohort study. J Intensive Care. 2020;8:45.","journal-title":"J Intensive Care"},{"key":"11139_CR20","doi-asserted-by":"publisher","first-page":"7141216","DOI":"10.1155\/2022\/7141216","volume":"2022","author":"X Huang","year":"2022","unstructured":"Huang X, Yuan S, Ling Y, Tan S, Huang T, Cheng H, Lyu J. The hemoglobin-to-red cell distribution width ratio to predict all-cause mortality in patients with sepsis-associated encephalopathy in the MIMIC-IV database. Int J Clin Pract. 2022;2022:7141216.","journal-title":"Int J Clin Pract"},{"issue":"10","key":"11139_CR21","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of america and the society for healthcare epidemiology of America. Clin Infect Dis. 2016;62(10):e51\u201377.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"11139_CR22","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3758\/s13428-016-0814-1","volume":"49","author":"MK Cain","year":"2017","unstructured":"Cain MK, Zhang Z, Yuan KH. Univariate and multivariate skewness and kurtosis for measuring nonnormality: prevalence, influence and estimation. Behav Res Methods. 2017;49(5):1716\u201335.","journal-title":"Behav Res Methods"},{"issue":"1","key":"11139_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bmsp.12103","volume":"71","author":"YJ Kim","year":"2018","unstructured":"Kim YJ, Cribbie RA. ANOVA and the variance homogeneity assumption: exploring a better gatekeeper. Br J Math Stat Psychol. 2018;71(1):1\u201312.","journal-title":"Br J Math Stat Psychol"},{"issue":"1","key":"11139_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41598-017-19120-0","volume":"8","author":"R Wei","year":"2018","unstructured":"Wei R, Wang J, Su M, Jia E, Chen S, Chen T, Ni Y. Missing value imputation approach for mass spectrometry-based metabolomics data. Sci Rep. 2018;8(1):663.","journal-title":"Sci Rep"},{"issue":"4","key":"11139_CR25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12350-014-9908-2","volume":"21","author":"B George","year":"2014","unstructured":"George B, Seals S, Aban I. Survival analysis and regression models. J Nucl Cardiol. 2014;21(4):686\u201394.","journal-title":"J Nucl Cardiol"},{"key":"11139_CR26","doi-asserted-by":"crossref","unstructured":"Tierney L. The R Statistical Computing Environment. In: Statistical Challenges in Modern Astronomy V: 2012\/\/ 2012. New York, NY: Springer New York; 2012. p. 435-447.","DOI":"10.1007\/978-1-4614-3520-4_41"},{"issue":"1","key":"11139_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12874-022-01664-z","volume":"22","author":"L Peng","year":"2022","unstructured":"Peng L, Peng C, Yang F, Wang J, Zuo W, Cheng C, Mao Z, Jin Z, Li W. Machine learning approach for the prediction of 30-day mortality in patients with sepsis-associated encephalopathy. BMC Med Res Methodol. 2022;22(1):183.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"11139_CR28","doi-asserted-by":"publisher","first-page":"e0293256","DOI":"10.1371\/journal.pone.0293256","volume":"18","author":"H Luo","year":"2023","unstructured":"Luo H, Li G, Yang B, Huang X, Chen Y, Shen W. Association between the first 24 hours PaCO2 and all-cause mortality of patients suffering from sepsis-associated encephalopathy after ICU admission: a retrospective study. PLoS One. 2023;18(10):e0293256.","journal-title":"PLoS One"},{"issue":"4","key":"11139_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/antibiotics12040681","volume":"12","author":"E Novy","year":"2023","unstructured":"Novy E, Martini\u00e8re H, Roger C. The current status and future perspectives of beta-lactam therapeutic drug monitoring in critically Ill patients. Antibiotics (Basel). 2023;12(4):681.","journal-title":"Antibiotics (Basel)"},{"issue":"12","key":"11139_CR30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s40264-017-0578-2","volume":"40","author":"S Deshayes","year":"2017","unstructured":"Deshayes S, Coquerel A, Verdon R. Neurological adverse effects attributable to \u03b2-Lactam antibiotics: a literature review. Drug Saf. 2017;40(12):1171\u201398.","journal-title":"Drug Saf"},{"issue":"5","key":"11139_CR31","first-page":"497","volume":"81","author":"M Beumier","year":"2015","unstructured":"Beumier M, Casu GS, Hites M, Wolff F, Cotton F, Vincent JL, Jacobs F, Taccone FS. Elevated \u03b2-lactam concentrations associated with neurological deterioration in ICU septic patients. Minerva Anestesiol. 2015;81(5):497\u2013506.","journal-title":"Minerva Anestesiol"},{"issue":"8","key":"11139_CR32","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1080\/15548627.2023.2175569","volume":"19","author":"JM Carosi","year":"2023","unstructured":"Carosi JM, Sargeant TJ. Rapamycin and Alzheimer disease: a hypothesis for the effective use of rapamycin for treatment of neurodegenerative disease. Autophagy. 2023;19(8):2386\u201390.","journal-title":"Autophagy"},{"issue":"8","key":"11139_CR33","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1080\/15548627.2019.1615823","volume":"15","author":"JM Carosi","year":"2019","unstructured":"Carosi JM, Sargeant TJ. Rapamycin and Alzheimer disease: a double-edged sword? Autophagy. 2019;15(8):1460\u20132.","journal-title":"Autophagy"},{"issue":"2","key":"11139_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4103\/0028-3886.284372","volume":"68","author":"J Hwang","year":"2020","unstructured":"Hwang J, Eun MY. Fatal metronidazole-induced encephalopathy. Neurol India. 2020;68(2):522\u20133.","journal-title":"Neurol India"},{"issue":"12","key":"11139_CR35","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/cid\/ciaa395","volume":"72","author":"N Daneman","year":"2021","unstructured":"Daneman N, Cheng Y, Gomes T, Guan J, Mamdani MM, Saxena FE, Juurlink DN. Metronidazole-associated neurologic events: a nested case-control study. Clin Infect Dis. 2021;72(12):2095\u2013100.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"11139_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cger.2017.02.002","volume":"33","author":"M Cesari","year":"2017","unstructured":"Cesari M, Calvani R, Marzetti E. Frailty in older persons. Clin Geriatr Med. 2017;33(3):293\u2013303.","journal-title":"Clin Geriatr Med"},{"issue":"7","key":"11139_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2174\/138920011796504527","volume":"12","author":"S Shi","year":"2011","unstructured":"Shi S, Klotz U. Age-related changes in pharmacokinetics. Curr Drug Metab. 2011;12(7):601\u201310.","journal-title":"Curr Drug Metab"},{"issue":"2","key":"11139_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40262-023-01213-x","volume":"62","author":"D Morales Castro","year":"2023","unstructured":"Morales Castro D, Dresser L, Granton J, Fan E. Pharmacokinetic alterations associated with critical illness. Clin Pharmacokinet. 2023;62(2):209\u201320.","journal-title":"Clin Pharmacokinet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11139-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11139-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11139-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:03:11Z","timestamp":1751414591000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11139-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11139"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11139-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"11 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement of ethical approval for this was waived by the Institutional Review Board of Yunnan New Kunhua Hospital, because the data was accessed from MIMIC-IV (a publicly available database). The need for written informed consent was waived by the Institutional Review Board of Yunnan New Kunhua Hospital due to retrospective nature of the study. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"858"}}